C3 Research is a full-service clinical research organization founded in 2008 by a team of clinical research experts. Founded on the principles of quality, integrity, responsiveness and the idea that any project, no matter its size, should be as big of a priority to a CRO as it is to the sponsor. Since our inception, C3 has provided service to biotechnology, pharmaceutical, medical device and diagnostic companies seeking highly skilled and comprehensive clinical research development services across the full spectrum of in-house capabilities including regulatory support, clinical trial management, data management, biostats and programming, medical writing, safety management and pharmacovigilance, and medical monitoring.
Utilizing industry proven best practices, C3 has developed an approach to managing clinical trials that uniquely positions us to partner with our clients to become a virtual extension of their clinical project team.
Our approach is simple: develop an intimate understanding of the science, the needs of the client and the needs of the project. Based on this in-depth analysis, we develop a solutions-based strategic plan to ensure the objectives of the development program are met.
Through the application of the C3 Model, we are committed to encouraging the innovation of our client partners to advance their science so that together we may improve the lives of patients.
A CRO Without Limits
C3 Research is dedicated to encouraging innovation while helping sponsors achieve their goals. We make an uncompromising commitment to sponsor satisfaction, striving to be thorough, responsive, and nimble as the needs of the sponsor and project evolve. Offering a full suite of solutions to our clients from pre-clinical services through regulatory submissions for approval, with an emphasis on clinical development of clinical trials, our team brings a wealth of knowledge to each study, having successfully managed clinical trials in a wide spectrum of therapeutic indications, across various geographic regions and phases of development.
- We leverage best-in-class technology to streamline processes, keep us connected, and bring our project teams together
- We maintain strategic relationships which allow us to provide coverage throughout the globe, meeting the needs of global and regional sponsors alike
Through our proprietary C3 Model, we offer sponsors the distinct advantage of deploying functional units and project teams wherever and whenever necessary, allowing us to strategically manage pilot programs on through their global pivotal studies.
Therapeutic Areas
Allergy
Healthy Volunteers
Neurology (CNS)
Pediatrics
Urology
Cardiovascular
Hematology
Nutrition
Podiatry
Vaccines
Dental Health
Hepatology
Women’s Health
Psychiatry
Dermatology
Immunology
Oncology
Endocrinology
Infectious Diseases
Ophthalmology
Rare Diseases
Family Medicine
Internal Medicine
Orthopedics
Rheumatology
Gastroenterology
Musculoskeletal
Otolaryngology
Sleep
Genetic Disease
Nephrology
Pain Management
Trauma
Investigational Product Types

Stages of Development

(FIH, SAD/MAD,
PK/PD,
Ethnobridging,
Umbrella,
Adaptive Designs, etc.)
(tQt, ADME,
Renal/Hepatic Clearance,
Food-Effect, DDI, etc.)
Geographic Regions Covered
